Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis

Overview of attention for article published in Blood, January 2000

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

patent: 9 patents

Readers on

mendeley: 25 Mendeley

So far, Altmetric has seen 9 patents that reference this research output.

Treatment of disease with antibodies against high molecular weight kininogen domain 5

Grant US-7332161-B2

United States of America

19 Feb 2008

CELL SURFACE TROPOMYOSIN AS A TARGET OF ANGIOGENESIS INHIBITION

Application WO-2003077872-A3

World Intellectual Property Organisation (WIPO)

18 May 2007

Therapeutic polypeptides, nucleic acids encoding same, and methods of use

Grant US-7034132-B2

United States of America

25 Apr 2006

Inhibition of angiogenesis by antibodies against high molecular weight kininogen domain 5

Grant US-6994852-B1

United States of America

07 Feb 2006

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 5 additional patents.